Neos Therapeutics, Inc. (NEOS) financial statements (2020 and earlier)

Company profile

Business Address 2940 N. HIGHWAY 360
GRAND PRAIRIE, TX 75050
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments2546504091
Cash and cash equivalents1746322491
Short-term investments8 1815 
Receivables27281464
Inventory, net of allowances, customer advances and progress billings11101363
Inventory11101363
Other current assets 4531
Other undisclosed current assets4  1 
Total current assets:6789835598
Noncurrent Assets
Operating lease, right-of-use asset3
Property, plant and equipment78875
Intangible assets, net (including goodwill)1315161617
Intangible assets, net (excluding goodwill)1315161617
Other noncurrent assets10022
Total noncurrent assets:2423252524
TOTAL ASSETS:9111110780123
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities474922138
Accounts payable7131185
Accrued liabilities40361153
Debt29158
Deferred revenue and credits154 
Other undisclosed current liabilities15    
Total current liabilities:6357382216
Noncurrent Liabilities
Long-term debt and lease obligation, including:443595926
Finance lease, liability0
Operating lease, liability3
Other undisclosed long-term debt and lease obligation 43595926
Liabilities, other than long-term debt13311
Deferred revenue and credits111
Deferred rent credit 1
Other liabilities000  
Business combination, contingent consideration, liability   00
Derivative instruments and hedges, liabilities122  
Other undisclosed noncurrent liabilities29  01
Total noncurrent liabilities:3446626028
Total liabilities:97104998244
Stockholders' equity
Stockholders' equity attributable to parent(6)88(2)78
Common stock00000
Treasury stock, value(0)(0)(0)(0)(0)
Additional paid in capital328325275199195
Accumulated other comprehensive income (loss)0 (0)(0) 
Accumulated deficit(334)(317)(266)(200)(117)
Total stockholders' equity:(6)88(2)78
TOTAL LIABILITIES AND EQUITY:9111110780123

Income statement (P&L) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Revenues65502594
Revenue, net2594
Cost of revenue
(Cost of Goods and Services Sold)
(25)(27)(12)(11)(6)
Gross profit:402313(2)(2)
Operating expenses(50)(67)(70)(74)(25)
Operating loss:(10)(43)(57)(76)(27)
Nonoperating income
(Other Nonoperating income)
21111
Interest and debt expense(8)(9) (1)(1)
Loss from continuing operations before income taxes:(17)(52)(56)(76)(26)
Income tax expense(0)    
Loss before gain (loss) on sale of properties:(17)(52)(56)(76)(26)
Other undisclosed net loss  (10)  
Net loss:(17)(52)(66)(76)(26)
Other undisclosed net loss attributable to parent   (7)(4)
Net loss attributable to parent:(17)(52)(66)(83)(31)
Preferred stock dividends and other adjustments    (2)
Net loss available to common stockholders, diluted:(17)(52)(66)(83)(33)

Comprehensive Income ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Net loss:(17)(52)(66)(76)(26)
Comprehensive loss:(17)(52)(66)(76)(26)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent00(0)(7) 
Comprehensive loss, net of tax, attributable to parent:(17)(52)(66)(83)(26)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: